| P50 | author | Steven G Deeks | Q57425986 |
| | David R Bangsberg | Q60227555 |
| | Constantin T Yiannoutsos | Q83393956 |
| | Torsten B Neilands | Q90862924 |
| P2093 | author name string | David V Glidden | |
| | Jeffrey N Martin | |
| | Elvin H Geng | |
| | Winnie Muyindike | |
| | Nneka Emenyonu | |
| | Nicolas Musinguzi | |
| | Mwebwesa Bosco Bwana | |
| P2860 | cites work | Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review | Q33302944 |
| | Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania | Q33330114 |
| | Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya | Q33388709 |
| | Multiple imputation: a primer | Q33646777 |
| | Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature | Q33988155 |
| | Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies | Q34139859 |
| | Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes | Q34556854 |
| | Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach | Q36712377 |
| | Contribution of tuberculosis to slim disease in Africa | Q36886103 |
| | Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa | Q37012911 |
| | Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants | Q37578947 |
| | Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study | Q39006642 |
| | Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries | Q46391119 |
| | The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. | Q50745207 |
| | Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. | Q51809092 |
| | Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. | Q53645693 |
| | A simplified approach of assessing adult chronic energy deficiency. | Q53848157 |
| | Determinants of Mortality and Nondeath Losses from an Antiretroviral Treatment Service in South Africa: Implications for Program Evaluation | Q58042135 |
| | Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy | Q58075270 |
| | Addressing an idiosyncrasy in estimating survival curves using double sampling in the presence of self-selected right censoring | Q74050374 |
| P921 | main subject | patient | Q181600 |
| | HIV | Q15787 |
| | anti-retroviral agent | Q50430310 |
| P304 | page(s) | 63-69 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Tropical Medicine and International Health | Q15765747 |
| P1476 | title | Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa | |
| P478 | volume | 15 Suppl 1 | |